missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-7 Protein
Click to view available options
Quantité:
10 μg
50 μg
Conditionnement:
10µg
50µg
Description
Measured in a cell proliferation assay using PHA-activated human peripheral blood lymphocytes (PBL). Yokota, T. et al. (1986) Proc. Natl. Acad. Sci. USA 83:5894. The ED50 for this effect is 0.1-0.5 ng/mL.
Spécification
Spécification
| Numéro d’adhésion | P13232 |
| À utiliser avec (application) | Bioactivity |
| Formule | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Identification génétique (Entrez) | 3574 |
| Poids moléculaire | 17 kDa |
| Quantité | 10 μg |
| Source | <EM>E. coli</EM>-derived human IL-7 protein Asp26-His177, with an N-terminal Met |
| Conditions de stockage | Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution |
| État réglementaire | RUO |
| Concentration en endotoxines | <0.01 EU per 1 μg of the protein by the LAL method. |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu